BillionToOne, Inc. Class A Share Price

BillionToOne, Inc. Class A Share Price

NASDAQ: BLLN | Small Cap
$114.71
+$1.07 (0.94%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BillionToOne, Inc. Class A Stock Performance

Open
$114.54
Prev. Close
$113.64
Circuit Range
N/A
Day Range
$113.00 - $115.20
Year Range
$62.08 - $150.35
Volume
36,637
Average Traded
$114.32

BillionToOne, Inc. Class A Share Price Today

As of 30 October 2026, BillionToOne, Inc. Class A's share price is $114.71. The stock opened at $114.54, compared to its previous close of $113.64. During today's trading session, BillionToOne, Inc. Class A's share price traded between $113.00 and $115.20, with an average price of $114.10. Over the past 52 weeks, the stock has recorded a high of $150.35 and a low of $62.08. In terms of performance, BillionToOne, Inc. Class A's share price has risen by 52.92% over the last six months and is down 11.76% on a year-on-year basis.

BillionToOne, Inc. Class A Share Price Chart

Line chart of the BillionToOne, Inc. Class A price trend over the selected period. The price rose overall, ranging from 112.67 to 115.10, ending at 114.71.
$113.00$115.20
L
Show Current Price
H

BillionToOne, Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$1.82B
PE Ratio (TTM)
178.94
Dividend Yield
0.00%
EPS (TTM)
$0.64
Revenue (TTM)
$305.11B
Return On Equity (TTM)
5.60%
Profit Margin
0.96%
Debt to Equity
0.17
Quarterly Earnings Growth YoY
N/A

BillionToOne, Inc. Class A Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026
Revenue$96.05$108.39$109.45
Net Profit$2.53$17.97$8.05
Net Profit Margin2.63%16.58%7.35%
Income ChangeN/A610.28%-55.20%

BillionToOne, Inc. Class A Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$305.11
Net Profit$2.92
Net Profit Margin0.96%
Income ChangeN/A

About BillionToOne, Inc. Class A

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

BillionToOne, Inc. Class A Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$107.47
$114.96
+8.11%
Sep 2026
$92.14
$106.33
+11.84%
Aug 2026
$137.38
$95.08
-31.38%
Jul 2026
$119.91
$138.56
+15.62%
Jun 2026
$95.24
$119.84
+21.25%
May 2026
$73.77
$98.84
+31.76%
Apr 2026
$77.64
$75.02
-4.56%
Mar 2026
$75.50
$78.60
+3.26%
Feb 2026
$85.11
$76.12
-7.85%
Jan 2026
$86.89
$82.60
+0.81%
Dec 2025
$126.25
$81.94
-36.97%
Nov 2025
$104.51
$130.00
N/A

BLLN Share Price FAQs